84 related articles for article (PubMed ID: 15563958)
21. Direct assessments of the antioxidant effects of propofol medium chain triglyceride/long chain triglyceride on the brain of stroke-prone spontaneously hypertensive rats using electron spin resonance spectroscopy.
Kobayashi K; Yoshino F; Takahashi SS; Todoki K; Maehata Y; Komatsu T; Yoshida K; Lee MC
Anesthesiology; 2008 Sep; 109(3):426-35. PubMed ID: 18719440
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of NAD(P)H oxidase alleviates impaired NOS-dependent responses of pial arterioles in type 1 diabetes mellitus.
Mayhan WG; Arrick DM; Sharpe GM; Patel KP; Sun H
Microcirculation; 2006; 13(7):567-75. PubMed ID: 16990215
[TBL] [Abstract][Full Text] [Related]
23. Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus.
Schäfer A; Fraccarollo D; Pförtsch S; Flierl U; Vogt C; Pfrang J; Kobsar A; Renné T; Eigenthaler M; Ertl G; Bauersachs J
Br J Pharmacol; 2008 Mar; 153(5):886-93. PubMed ID: 17891166
[TBL] [Abstract][Full Text] [Related]
24. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.
Gao L; Mann GE
Cardiovasc Res; 2009 Apr; 82(1):9-20. PubMed ID: 19179352
[TBL] [Abstract][Full Text] [Related]
25. Protein kinase C-gamma activation in the early streptozotocin diabetic rat lens.
Lin D; Harris R; Stutzman R; Zampighi GA; Davidson H; Takemoto DJ
Curr Eye Res; 2007 Jun; 32(6):523-32. PubMed ID: 17612968
[TBL] [Abstract][Full Text] [Related]
26. Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension.
Peixoto EB; Pessoa BS; Biswas SK; Lopes de Faria JB
Am J Nephrol; 2009; 29(4):309-18. PubMed ID: 18849601
[TBL] [Abstract][Full Text] [Related]
27. Occurrence of oxidative impairments, response of antioxidant defences and associated biochemical perturbations in male reproductive milieu in the Streptozotocin-diabetic rat.
Shrilatha B;
Int J Androl; 2007 Dec; 30(6):508-18. PubMed ID: 17573857
[TBL] [Abstract][Full Text] [Related]
28. Diabetic neuropathy and oxidative stress.
Pop-Busui R; Sima A; Stevens M
Diabetes Metab Res Rev; 2006; 22(4):257-73. PubMed ID: 16506271
[TBL] [Abstract][Full Text] [Related]
29. Pyritinol reduces nociception and oxidative stress in diabetic rats.
Jiménez-Andrade GY; Reyes-García G; Sereno G; Ceballos-Reyes G; Vidal-Cantú GC; Granados-Soto V
Eur J Pharmacol; 2008 Aug; 590(1-3):170-6. PubMed ID: 18593582
[TBL] [Abstract][Full Text] [Related]
30. Moderate exercise with a dietary vitamin C and e combination protects against streptozotocin-induced oxidative damage to the kidney and lens in pregnant rats.
Simşek M; Naziroğlu M; Erdinç A
Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):53-9. PubMed ID: 15662597
[TBL] [Abstract][Full Text] [Related]
31. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
Saini AK; Kumar H S A; Sharma SS
Eur J Pharmacol; 2007 Jul; 568(1-3):164-72. PubMed ID: 17521626
[TBL] [Abstract][Full Text] [Related]
32. Role of the PKC/CPI-17 pathway in enhanced contractile responses of mesenteric arteries from diabetic rats to alpha-adrenoceptor stimulation.
Mueed I; Zhang L; MacLeod KM
Br J Pharmacol; 2005 Dec; 146(7):972-82. PubMed ID: 16205724
[TBL] [Abstract][Full Text] [Related]
33. The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinopathy.
Curtis TM; Scholfield CN
Diabetes Metab Res Rev; 2004; 20(1):28-43. PubMed ID: 14737743
[TBL] [Abstract][Full Text] [Related]
34. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.
Cai L; Wang Y; Zhou G; Chen T; Song Y; Li X; Kang YJ
J Am Coll Cardiol; 2006 Oct; 48(8):1688-97. PubMed ID: 17045908
[TBL] [Abstract][Full Text] [Related]
35. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
Sayyed SG; Kumar A; Sharma SS
Life Sci; 2006 Jul; 79(8):777-83. PubMed ID: 16581090
[TBL] [Abstract][Full Text] [Related]
36. Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats.
Milani E; Nikfar S; Khorasani R; Zamani MJ; Abdollahi M
Comp Biochem Physiol C Toxicol Pharmacol; 2005 Feb; 140(2):251-5. PubMed ID: 15907769
[TBL] [Abstract][Full Text] [Related]
37. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
Nam SM; Lee MY; Koh JH; Park JH; Shin JY; Shin YG; Koh SB; Lee EY; Chung CH
Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
[TBL] [Abstract][Full Text] [Related]
38. Activation of oxidative stress signaling that is implicated in apoptosis with a mouse model of diabetic embryopathy.
Yang P; Zhao Z; Reece EA
Am J Obstet Gynecol; 2008 Jan; 198(1):130.e1-7. PubMed ID: 18166327
[TBL] [Abstract][Full Text] [Related]
39. Atorvastatin reduces the plasma lipids and oxidative stress but did not reverse the inhibition of prostacyclin generation by aortas in streptozotocin diabetic rats.
Mahfouz MM; Kummerow FA
Prostaglandins Other Lipid Mediat; 2005 May; 76(1-4):59-73. PubMed ID: 15967162
[TBL] [Abstract][Full Text] [Related]
40. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.
Osawa T; Kato Y
Ann N Y Acad Sci; 2005 Jun; 1043():440-51. PubMed ID: 16037265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
